Translational Sciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Employees
- -
- Market Cap
- -
Strategy for Improving Stroke Treatment Response
- First Posted Date
- 2023-07-17
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Translational Sciences, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT05948566
- Locations
- 🇺🇸
North Shore University Hospital, Manhasset, New York, United States
🇺🇸Mount Sinai West, New York, New York, United States
🇺🇸The Mount Sinai Hospital, New York, New York, United States
Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Translational Sciences, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05408546
- Locations
- 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States
Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer
Phase 1
- Conditions
- Cerebral IschemiaMyocardial InfarctionThrombosisVenous ThrombosisPulmonary Embolism
- Interventions
- Biological: TS23
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2016-12-23
- Lead Sponsor
- Translational Sciences, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03001544
© Copyright 2025. All Rights Reserved by MedPath